Brief: Janux Therapeutics Announces First Patient Dosed In Early-Stage Trial
20/04/2023 21:26
April 20 (Reuters) - Janux Therapeutics Inc JANX.O :
* JANUX THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED WITH
JANX008 IN
FIRST-IN-HUMAN PHASE 1 CLINICAL TRIAL IN PATIENTS WITH SOLID
TUMORS
* JANUX THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED WITH
JANX008 IN
FIRST-IN-HUMAN PHASE 1 CLINICAL TRIAL IN PATIENTS WITH SOLID
TUMORS
Source text for Eikon: ID:nBwbhdsFYa
Further company coverage: JANX.O
((Reuters.Briefs@thomsonreuters.com;))